Fewer major bleeds with edoxaban than with warfarin, but treatment benefit unclear (ENGAGE-AF)

Fewer major bleeds with edoxaban than with warfarin, but treatment benefit unclear (ENGAGE-AF) is a topic covered in the EE+ POEM Archive.

To view the entire topic, please or purchase a subscription.

Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:

Evidence Central